Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |